Lindsay A MD Rosenwald's Net Worth

$113 Million

Who is Lindsay A MD Rosenwald?

Lindsay A MD Rosenwald has an estimated net worth of $113 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, MANHATTAN PHARMACEUTICALS INC, NATIONAL HOLDINGS CORP, CB Pharma Acquisition Corp., Fortress Biotech, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., Checkpoint Therapeutics, Inc., KERYX BIOPHARMACEUTICALS INC, Journey Medical Corp, GENTA INC DE/, JAVELIN PHARMACEUTICALS, INC, Innovive Pharmaceuticals, Inc., Cougar Biotechnology, Inc., SITKA SCIENCES, INC., SEWARD SCIENCES, INC., NORTON SOUND ACQUISITION CORP., KODIAK SCIENCES, INC., KANAI SCIENCES, INC., DENALI SCIENCES, INC., CORDOVA SCIENCES, INC., CHITINA SCIENCES, INC., BRISTOL BAY SCIENCES, INC., ARCTIC ACQUISITION CORP., Paramount Acquisition Corp, NOVADEL PHARMA INC, CYPRESS BIOSCIENCE INC, and DOR BIOPHARMA INC.

SEC CIK

Lindsay A MD Rosenwald's CIK is 0000941841

Past Insider Trading and Trends

2005 was Lindsay A MD Rosenwald's most active year for acquiring shares with 82 total transactions. Lindsay A MD Rosenwald's most active month to acquire stocks was the month of December. 2004 was Lindsay A MD Rosenwald's most active year for disposing of shares, totalling 47 transactions. Lindsay A MD Rosenwald's most active month to dispose stocks was the month of January. 2023 saw Lindsay A MD Rosenwald paying a total of $5,378,051.02 for 7,442,937 shares, this is the most they've acquired in one year. In 2004 Lindsay A MD Rosenwald cashed out on 29,024,124 shares for a total of $72,882,265.51, their largest year based on trade value.